India has approved further clinical trials for its first homegrown mRNA-based COVID-19 vaccine developed by Gennova Biopharmaceuticals Ltd, the government said on Tuesday, after the shot was found to be safe and effective in an early-stage study.
Gennova is among a few pharmaceutical firms worldwide, including Moderna Inc (MRNA.O) and Pfizer Inc (PFE.N), to use mRNA technology in its coronavirus shot. These vaccines do not use a live virus to generate an immune response but prompt the human body to make a protein that triggers one.
https://www.newsofbahrain.com/world/74843.html